Jaeschke H, Wendel A
Toxicology. 1986 Apr;39(1):59-70. doi: 10.1016/0300-483x(86)90159-9.
After 14 days of oral butylated hydroxyanisole (BHA) administration (1000 mg/kg/day) the tissue glutathione levels of male NMRI mice were increased by 74-141% in liver, lung, duodenum and intestine and after similar butylated hydroxytoluene (BHT) treatment by 18-85% in the liver, lung, spleen and the gastrointestinal tract. Doses of 100 mg/kg/day significantly elevated the glutathione content in the lung (BHA, BHT), duodenum (BHA) and intestine (BHA), while 10 mg/kg/day affected only lung glutathione content (BHA). BHA treatment (1000 mg/kg/day) induced GST activities significantly (138-1335%) in all organs investigated except the spleen, i.e. liver, lung, kidney and the entire gastrointestinal tract, while a similar dose of BHT increased GST activities in the liver, duodenum, intestine and colon by 26-339%. Daily doses of 100 mg/kg/day significantly induced GST activities only in the liver (BHA, BHT), lung (BHA) and kidney (BHA). Lower doses of BHA or BHT did not significantly affect GST activities in the organs investigated (except 10 mg BHA/kg/day in the lung). Comparison of the time course of induction of the glutathione conjugation system in various organs after different doses of antioxidants indicated no change between 5 and 14 days of treatment with all doses used (1-1000 mg/kg). Only the lung glutathione level showed a tendency to increase with low dose BHA by extending the time of treatment. The time course of the liver glutathione content between single doses of 100 mg/kg BHA or BHT revealed an initial decline followed by an increase above control values 2 days (BHA) or 5 days (BHT) after the first application. The glutathione levels of the lung and the duodenum increased without a preceding decline. Only the second dose of BHT caused a temporary decrease to control values of the elevated glutathione level in the duodenum. All animals (at any dose of BHA or BHT) showed control values of serum transaminase activities. These results suggest: The induction threshold of the glutathione conjugation system in various mouse organs is greater than or equal to 100 mg/kg for BHA and BHT. Chronic administration of these compounds did not change these results (except the lung glutathione level after low dose BHA). Elevated hepatic glutathione levels might be the result of an activated synthesis caused by a preceding loss of glutathione. Chronic BHA or BHT treatment did not cause hepatotoxic effects, as evaluated by serum transaminases, in male mice.
给予雄性NMRI小鼠口服丁基羟基茴香醚(BHA)14天(1000毫克/千克/天)后,肝脏、肺、十二指肠和肠道组织中的谷胱甘肽水平升高了74 - 141%;给予类似剂量的丁基羟基甲苯(BHT)处理后,肝脏、肺、脾脏和胃肠道中的谷胱甘肽水平升高了18 - 85%。100毫克/千克/天的剂量显著提高了肺(BHA、BHT)、十二指肠(BHA)和肠道(BHA)中的谷胱甘肽含量,而10毫克/千克/天仅影响肺中的谷胱甘肽含量(BHA)。BHA处理(1000毫克/千克/天)显著诱导了除脾脏外所有研究器官(即肝脏、肺、肾脏和整个胃肠道)中的谷胱甘肽S - 转移酶(GST)活性(138 - 1335%),而相同剂量的BHT使肝脏、十二指肠、肠道和结肠中的GST活性提高了26 - 339%。每日100毫克/千克/天的剂量仅在肝脏(BHA、BHT)、肺(BHA)和肾脏(BHA)中显著诱导了GST活性。较低剂量的BHA或BHT对所研究器官中的GST活性没有显著影响(肺中10毫克BHA/千克/天除外)。比较不同剂量抗氧化剂处理后各器官中谷胱甘肽结合系统诱导的时间进程表明,在所使用的所有剂量(1 - 1000毫克/千克)处理5至14天期间没有变化。仅肺中的谷胱甘肽水平在低剂量BHA延长处理时间时有升高的趋势。单次给予100毫克/千克BHA或BHT后,肝脏中谷胱甘肽含量的时间进程显示,给药后最初下降,然后在首次给药后2天(BHA)或5天(BHT)升至对照值以上。肺和十二指肠中的谷胱甘肽水平升高且无先前下降。只有第二次给予BHT导致十二指肠中升高的谷胱甘肽水平暂时降至对照值。所有动物(任何剂量的BHA或BHT)的血清转氨酶活性均显示为对照值。这些结果表明:BHA和BHT在小鼠各器官中诱导谷胱甘肽结合系统的阈值大于或等于100毫克/千克。长期给予这些化合物并没有改变这些结果(低剂量BHA处理后的肺谷胱甘肽水平除外)。肝脏中谷胱甘肽水平升高可能是先前谷胱甘肽损失导致合成激活的结果。以血清转氨酶评估,长期BHA或BHT处理对雄性小鼠没有造成肝毒性作用。